| Product Code: ETC10767919 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Israel continues to rely on top exporting countries like Switzerland, USA, Germany, China, and Belgium for peptide oligonucleotide imports in 2024. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, suggesting potential challenges for diversification. Despite a negative Compound Annual Growth Rate (CAGR) from 2020 to 2024, there was a positive growth rate in 2024, indicating a potential turnaround in the market. Israeli importers should closely monitor these trends and explore opportunities for enhancing competitiveness and expanding their supplier base.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Peptide Oligonucleotide Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Peptide Oligonucleotide Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Peptide Oligonucleotide Market - Industry Life Cycle |
3.4 Israel Peptide Oligonucleotide Market - Porter's Five Forces |
3.5 Israel Peptide Oligonucleotide Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Israel Peptide Oligonucleotide Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.7 Israel Peptide Oligonucleotide Market Revenues & Volume Share, By Manufacturing Process, 2021 & 2031F |
3.8 Israel Peptide Oligonucleotide Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Israel Peptide Oligonucleotide Market Revenues & Volume Share, By Technology Integration, 2021 & 2031F |
4 Israel Peptide Oligonucleotide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Peptide Oligonucleotide Market Trends |
6 Israel Peptide Oligonucleotide Market, By Types |
6.1 Israel Peptide Oligonucleotide Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Peptide Oligonucleotide Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Israel Peptide Oligonucleotide Market Revenues & Volume, By Custom Peptide Synthesis, 2021 - 2031F |
6.1.4 Israel Peptide Oligonucleotide Market Revenues & Volume, By Oligonucleotide Manufacturing, 2021 - 2031F |
6.1.5 Israel Peptide Oligonucleotide Market Revenues & Volume, By API Development, 2021 - 2031F |
6.1.6 Israel Peptide Oligonucleotide Market Revenues & Volume, By cGMP Manufacturing, 2021 - 2031F |
6.1.7 Israel Peptide Oligonucleotide Market Revenues & Volume, By Formulation Development, 2021 - 2031F |
6.2 Israel Peptide Oligonucleotide Market, By Molecule Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Peptide Oligonucleotide Market Revenues & Volume, By RNA-Based, 2021 - 2031F |
6.2.3 Israel Peptide Oligonucleotide Market Revenues & Volume, By DNA-Based, 2021 - 2031F |
6.2.4 Israel Peptide Oligonucleotide Market Revenues & Volume, By Hybrid Molecules, 2021 - 2031F |
6.2.5 Israel Peptide Oligonucleotide Market Revenues & Volume, By Small Peptides, 2021 - 2031F |
6.2.6 Israel Peptide Oligonucleotide Market Revenues & Volume, By Large Peptides, 2021 - 2031F |
6.3 Israel Peptide Oligonucleotide Market, By Manufacturing Process |
6.3.1 Overview and Analysis |
6.3.2 Israel Peptide Oligonucleotide Market Revenues & Volume, By Solid Phase Synthesis, 2021 - 2031F |
6.3.3 Israel Peptide Oligonucleotide Market Revenues & Volume, By Liquid Phase Synthesis, 2021 - 2031F |
6.3.4 Israel Peptide Oligonucleotide Market Revenues & Volume, By Hybrid Synthesis, 2021 - 2031F |
6.3.5 Israel Peptide Oligonucleotide Market Revenues & Volume, By Enzymatic Synthesis, 2021 - 2031F |
6.3.6 Israel Peptide Oligonucleotide Market Revenues & Volume, By Recombinant Technology, 2021 - 2031F |
6.4 Israel Peptide Oligonucleotide Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Peptide Oligonucleotide Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 Israel Peptide Oligonucleotide Market Revenues & Volume, By Biotech Firms, 2021 - 2031F |
6.4.4 Israel Peptide Oligonucleotide Market Revenues & Volume, By Contract Research Organizations, 2021 - 2031F |
6.4.5 Israel Peptide Oligonucleotide Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Israel Peptide Oligonucleotide Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5 Israel Peptide Oligonucleotide Market, By Technology Integration |
6.5.1 Overview and Analysis |
6.5.2 Israel Peptide Oligonucleotide Market Revenues & Volume, By AI-Driven Process Optimization, 2021 - 2031F |
6.5.3 Israel Peptide Oligonucleotide Market Revenues & Volume, By Continuous Manufacturing, 2021 - 2031F |
6.5.4 Israel Peptide Oligonucleotide Market Revenues & Volume, By Automated Quality Control, 2021 - 2031F |
6.5.5 Israel Peptide Oligonucleotide Market Revenues & Volume, By High-Throughput Screening, 2021 - 2031F |
6.5.6 Israel Peptide Oligonucleotide Market Revenues & Volume, By Bioinformatics Integration, 2021 - 2031F |
7 Israel Peptide Oligonucleotide Market Import-Export Trade Statistics |
7.1 Israel Peptide Oligonucleotide Market Export to Major Countries |
7.2 Israel Peptide Oligonucleotide Market Imports from Major Countries |
8 Israel Peptide Oligonucleotide Market Key Performance Indicators |
9 Israel Peptide Oligonucleotide Market - Opportunity Assessment |
9.1 Israel Peptide Oligonucleotide Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Israel Peptide Oligonucleotide Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.3 Israel Peptide Oligonucleotide Market Opportunity Assessment, By Manufacturing Process, 2021 & 2031F |
9.4 Israel Peptide Oligonucleotide Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Israel Peptide Oligonucleotide Market Opportunity Assessment, By Technology Integration, 2021 & 2031F |
10 Israel Peptide Oligonucleotide Market - Competitive Landscape |
10.1 Israel Peptide Oligonucleotide Market Revenue Share, By Companies, 2024 |
10.2 Israel Peptide Oligonucleotide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here